share_log

Supernus Pharmaceuticals Sees FY24 Total Revenue $630M-$650M Vs $619.505M Est.

Benzinga ·  Nov 4, 2024 21:11
Supernus Pharmaceuticals Sees FY24 Total Revenue $630M-$650M Vs $619.505M Est.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment